Patients in the United States are depending on the emergency department (ED) for care more and more, a trend that has had a significant impact on imaging utilization.

French drugmaker Sanofi is cutting 466 jobs as part of an R&D “reshuffle” that will also put an end to the company’s new research efforts in cardiology.

The late, great business guru Peter Drucker (d. 2005) held that management is doing things right while leadership is doing the right things. The observation is timeless across industries, but “the right things” surely change over time and within arenas of human endeavor.

HHS has sent its proposal to base certain drug prices on an international index to the White House last week, according to a report from The Hill.

CMS on June 21 issued its finalized national coverage determination for TAVR—one that reportedly offers greater flexibility for hospitals and providers.

Two major, global pharmaceutical companies ––AbbVie and Allergan––are merging in a deal worth approximately $63 billion.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) continued a busy four-day stretch by introducing several new officers during its 2019 Annual Meeting in Anaheim, California.

Selecting a staff member to serve as a director of prostate imaging can improve compliance with technical standards and lead to better overall patient care, according to findings published in the American Journal of Roentgenology.